Factors Affecting Human IgE and IgG Responses to Allergen-Like Schistosoma mansoni Antigens: Molecular Structure and Patterns of in vivo Exposure

Background: The human IgE response is associated with allergy and with host defence against parasitic worms. A response to Sm22.6, the dominant IgE antigen in adult Schistosoma mansoni worms, correlates with resistance to re-infection after treatment. Sm22.6 is one of a family of EF-hand containing parasite proteins with sequence similarity to dynein light chain (DLC) and with major non-parasite allergens. Here we compare human IgE and IgG responses to other family members, Sm20.8 and Sm21.7, as well as to SmDLC1, relating these to antigen structure and expression in parasite life stages. Methods: Recombinant antigens were used in ELISA to measure antibody isotype responses in 177 cases from an endemic area, before and 7 weeks after treatment. Parasite antigen expression was assessed by RT-PCR and Western blotting. Results: Levels of antibodies to Sm22.6 and Sm20.8 (but not to Sm21.7 or SmDLC1) showed posttreatment increases in all but young children. Many produced IgE to Sm22.6 and Sm20.8 (2 EF-hands), few to Sm21.7 (1 EF-hand) or SmDLC1 (no EF-hands). Sm21.7 was expressed in cercariae, adults and eggs, Sm22.6 and Sm20.8 were concentrated in the adult. Conclusions: These studies suggest that IgE antigens Sm22.6 and Sm20.8 are only released to boost antibodies when adult worms die, whilst Sm21.7 and SmDLC1 are released constantly from eggs dying in host tissue. IgE responses to these allergen-like molecules may be influenced by patterns of exposure and the number of EF-hand motifs.

[1]  F. Parra,et al.  Cloning and expression in Escherichia coli of a Fasciola hepatica gene encoding a calcium-binding protein. , 1999, Molecular and biochemical parasitology.

[2]  G. Weil,et al.  Human antibody responses to Brugia malayi antigens in brugian filariasis. , 1999, International journal for parasitology.

[3]  G. Riveau,et al.  Human IgE responses to rSm22.6 are associated with infection intensity rather than age per se, in a recently established focus of Schistomiasis mansoni , 1998, Tropical medicine & international health : TM & IH.

[4]  Yuesheng Li,et al.  Immunogenicity and immunolocalization of the 22.6 kDa antigen of Schistosoma japonicum , 2000, Parasite immunology.

[5]  D. Dunne,et al.  The isolation of a 22 kDa band after SDS‐PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection , 1997, Parasite immunology.

[6]  R. Valenta,et al.  Calcium–Binding Allergens: From Plants to Man , 1998, International Archives of Allergy and Immunology.

[7]  L. Elfman,et al.  Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. , 1997, Biochemical and biophysical research communications.

[8]  G. Feldman,et al.  Physiologic Oxygen Tensions Limit Oxidant‐Mediated Killing of Schistosome Eggs by Inflammatory Cells and Isolated Granulomas , 1990, Journal of leukocyte biology.

[9]  R. Geha,et al.  The regulation of immunoglobulin E class-switch recombination , 2003, Nature Reviews Immunology.

[10]  T. Wynn,et al.  Exploiting worm and allergy models to understand Th2 cytokine biology , 2005, Current opinion in allergy and clinical immunology.

[11]  N. Mendell,et al.  Genetic transmission of serum IgE Levels. , 1981, American journal of medical genetics.

[12]  Heimo Breiteneder,et al.  Pollen allergens are restricted to few protein families and show distinct patterns of species distribution. , 2006, The Journal of allergy and clinical immunology.

[13]  N. Kabatereine,et al.  The relationship between age, sex, egg‐count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community , 2003, Tropical medicine & international health : TM & IH.

[14]  Maria Yazdanbakhsh,et al.  Allergy, parasites, and the hygiene hypothesis. , 2002, Science.

[15]  M. Woolhouse,et al.  Seeking the ghost of worms past , 1999, Nature Medicine.

[16]  N Katz,et al.  A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. , 1972, Revista do Instituto de Medicina Tropical de Sao Paulo.

[17]  D. Dunne,et al.  The development of schistosomiasis mansoni in an immunologically naive immigrant population in Masongaleni, Kenya , 1998, Parasitology.

[18]  K. Hoffmann,et al.  Molecular Identification of a Schistosoma mansoni Tegumental Protein with Similarity to Cytoplasmic Dynein Light Chains* , 1996, The Journal of Biological Chemistry.

[19]  M. Mohamed,et al.  Characterization of Sm20.8, a member of a family of schistosome tegumental antigens. , 1998, Molecular and biochemical parasitology.

[20]  A. Simpson,et al.  Molecular cloning and characterisation of the 22-kilodalton adult Schistosoma mansoni antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes. , 1991, Molecular and biochemical parasitology.

[21]  S. Durham,et al.  Mechanisms of immunotherapy. , 2004, The Journal of allergy and clinical immunology.

[22]  A. Prata,et al.  Evidence for an association between human resistance to Schistosoma mansoni and high anti‐larval IgE levels , 1991, European journal of immunology.

[23]  K. Hoffmann,et al.  Molecular Characterization of a 20.8-kDa Schistosoma mansoni Antigen , 1997, The Journal of Biological Chemistry.

[24]  A. Sher,et al.  Mechanisms of immune evasion in schistosomiasis. , 1987, Contributions to microbiology and immunology.

[25]  J. David,et al.  Cloning of a developmentally regulated tegument antigen of Schistosoma mansoni. , 1986, Molecular and biochemical parasitology.

[26]  D. Carpenter,et al.  Carriage of DRB1*13 Is Associated with Increased Posttreatment IgE Levels against Schistosoma mansoni Antigens and Lower Long-Term Reinfection Levels1 , 2006, The Journal of Immunology.

[27]  P. Fallon,et al.  Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm , 1997, Parasite immunology.

[28]  A. Capron,et al.  Immunoglobulin E and effector cells in schistosomiasis. , 1994, Science.

[29]  D. McManus,et al.  Purification of a recombinant Schistosoma japonicum antigen homologous to the 22-kDa membrane-associated antigen of S. mansoni, a putative vaccine candidate against schistosomiasis. , 1994, Gene.

[30]  H. Madsen,et al.  Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[31]  P. Sobhon,et al.  An analysis of the calcium-binding protein 1 of Fasciola gigantica with a comparison to its homologs in the phylum Platyhelminthes. , 2006, Molecular and biochemical parasitology.

[32]  C. Grevelding,et al.  Molecular characterization of omega-1: a hepatotoxic ribonuclease from Schistosoma mansoni eggs. , 2005, Molecular and biochemical parasitology.

[33]  G. Braun,et al.  Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment , 1996, Infection and immunity.

[34]  R. Sturrock,et al.  A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man , 1995, Parasitology.

[35]  A. Capron,et al.  Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection , 1992, European journal of immunology.

[36]  Jörg Schultz,et al.  HMM Logos for visualization of protein families , 2004, BMC Bioinformatics.

[37]  C. Akdis,et al.  Are regulatory T cells the target of venom immunotherapy? , 2005, Current opinion in allergy and clinical immunology.

[38]  C. King,et al.  Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis , 2005, The Lancet.

[39]  P. Francis,et al.  Cloning of a 21.7-kDa vaccine-dominant antigen gene of Schistosoma mansoni reveals an EF hand-like motif. , 1992, Molecular and biochemical parasitology.

[40]  R. Hayes,et al.  Resistance to reinfection with Schistosoma haematobium in Gambian children: analysis of their immune responses. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[41]  I. Bellinghausen,et al.  The Role of Interleukin 10 in the Regulation of Allergic Immune Responses , 2001, International Archives of Allergy and Immunology.

[42]  M. Yazdanbakhsh,et al.  Human IgE response to the Schistosoma haematobium 22·6 kDa antigen , 2004, Parasite immunology.

[43]  M. Santiago,et al.  Identification of the Schistosoma japonicum 22.6–kDa Antigen as a Major Target of the Human IgE Response: Similarity of IgE–Binding Epitopes to Allergen Peptides , 1998, International Archives of Allergy and Immunology.

[44]  B. Mordmüller,et al.  Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. , 1996, The Journal of infectious diseases.

[45]  N. Kabatereine,et al.  Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns , 1999, Parasitology.

[46]  D. McManus,et al.  Production of IgE antibodies against the 22 kDa tegumental membrane‐associated antigen of schistosomes is directed by the antigen itself , 1997, Parasite immunology.